Open AccessCOVID-19 THERAPEUTICAL OPTIONS: OVERVIEW ON CURRENTLY ANTIMALARIALS AND ANTIPARASITIC DRUGS USED
Author(s) -
Idrys Henrique Leite Guedes,
Gregório Dantas dos Santos,
Antônio Bonildo Freire Viana,
Geldane da Silva Araújo,
Tálio Câmara Pinto dos Santos,
Cláudia Jassica Gonçalves Moreno,
Silvia Donato
Publication year - 2021
Publication title -
health and society
Language(s) - English
Resource type - Journals
ISSN - 2763-5724
DOI - 10.51249/hes01.04.2021.453
Subject(s) - covid-19 , medicine , intensive care medicine , adverse effect , pharmacology , antiparasitic , drug , antiparasitic agent , coronavirus , virology , infectious disease (medical specialty) , disease , pathology , outbreak
Given the amount of scientific knowledge produced and published daily about the new corovavirus, this study sought to review evidence on some of the drugs used to treat Acute Respiratory Infection Syndrome caused by the COVID-19 virus. Thus, antimalarials and antiparasitics were evaluated regarding chemical and pharmacological aspects, including mechanism of action, toxicity, adverse effects and recommendation for use in the treatment of COVID-19.